We are live on ! Find out more
CPHI icon

China Pharma Holdings
CPHI

7 hedge funds and large institutions have $73.8K invested in China Pharma Holdings in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

63% more capital invested

Capital invested by funds: $45.4K → $73.8K (+$28.5K)

40% more funds holding

Funds holding: 5 → 7 (+2)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.02% less ownership

Funds ownership: 0.05% → 0.04% (-0.02%)

Holders
7
Holders Change
+2
Holders Change %
+40%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$20.3K
2
Citadel Advisors
Citadel Advisors
Florida
+$18.6K
3
JP Morgan Chase
JP Morgan Chase
New York
+$7.34K
4
UBS Group
UBS Group
Switzerland
+$3.85K
5
HF
HRT Financial
New York
+$2.36K

Top Sellers

Rank Fund Capital Flow
1
TSS
Two Sigma Securities
New York
-$9.01K
2
VF
Virtu Financial
New York
-$7.87K
3
Renaissance Technologies
Renaissance Technologies
New York
-$5K

CPHI Hedge Fund Activity: Q4 2023 in Review

7 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q4 2023, worth a combined $73.8K — up 63% from $45.4K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new CPHI positions and 2 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Millennium Management, adding an estimated $20.3K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $9.01K sold.

  • 7 institutional investors held China Pharma Holdings (CPHI) as of Q4 2023, up from 5 in Q3 2023.
  • Funds reported $73.8K of China Pharma Holdings stock for Q4 2023, up 63% quarter-over-quarter.
  • 4 funds opened new China Pharma Holdings positions in Q4 2023 and 2 closed out, a net change of +2 holders.
  • The largest China Pharma Holdings buyer in Q4 2023 was Millennium Management, an estimated $20.3K added.
  • The largest China Pharma Holdings seller in Q4 2023 was Two Sigma Securities, an estimated $9.01K sold.

Based on aggregated 13F filings for Q4 2023.